Werewolf Therapeutics, Inc.

HOWL · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$71-$37-$54-$50
Dep. & Amort.$2$2$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$9$8$7$4
Change in WC$3-$6$3$2
Other Non-Cash$1$1$2$1
Operating Cash Flow-$56-$33-$41-$43
Investing Activities
PP&E Inv.-$0-$1-$4-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$1-$4-$0
Financing Activities
Debt Repay.-$10$40$0$0
Stock Issued$24$18$16$112
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$0-$2
Financing Cash Flow$13$58$16$109
Forex Effect$0$0$0$0
Net Chg. in Cash-$43$25-$28$66
Supplemental Information
Beg. Cash$156$131$159$93
End Cash$112$156$131$159
Free Cash Flow-$56-$33-$44-$43